Kamdar, M. K., Abramson, J. S., Sehgal, A., Solomon, S. R., Gordon, L. I., Lunning, M. A., Ghosh, N., Glass, B., Mielke, S., Mutsaers, P., Morschhauser, F., Izutsu, K., Braun, R., Strocchia, M., Mittal, M., Andreola, G., Arnason, J. E. (2026). Longitudinal safety of lisocabtagene maraleucel (liso-cel) in patients (pt) with second-line or later (2L+) large B-cell lymphoma (LBCL).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7031